What management or medication can be given to this patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Anaphylaxis

Immediately inject epinephrine 0.01 mg/kg intramuscularly (IM) in the mid-outer thigh (vastus lateralis muscle) as soon as anaphylaxis is recognized, with a maximum dose of 0.3 mg in prepubertal children and 0.5 mg in teenagers. 1

Immediate Recognition and Initial Actions

Anaphylaxis presents with sudden onset (minutes to hours) after trigger exposure and involves multiple organ systems 1:

  • Skin/mucosal: itching, hives, swelling, flushing 1
  • Respiratory: throat tightness, stridor, dyspnea, bronchospasm, wheeze, cyanosis 1
  • Cardiovascular: tachycardia, hypotension, weak pulse, dizziness, collapse, shock 1
  • Gastrointestinal: nausea, vomiting, crampy abdominal pain, diarrhea 1
  • Neurologic: sense of doom, altered mental status, confusion 1

Critical first steps 1:

  • Stop any medication infusion immediately if drug-related 1
  • Maintain IV access 1
  • Assess ABCs (Airway, Breathing, Circulation) and level of consciousness 1
  • Call for emergency assistance (911/EMS in community, resuscitation team in hospital) 1

Patient Positioning

Position based on presenting symptoms 1:

  • Hypotension: Trendelenburg position 1
  • Respiratory distress: sitting upright 1
  • Unconscious: recovery position 1
  • Never allow standing, walking, or running 1

Epinephrine Administration

Primary treatment 1:

  • Dose: 0.01 mg/kg IM (1 mg/mL dilution) 1
  • Maximum: 0.3 mg prepubertal, 0.5 mg teenagers 1
  • Site: mid-outer thigh (vastus lateralis) 1
  • Repeat: second injection at 5-15 minutes if inadequate response 1
  • Note: 6-19% of pediatric patients require a second dose 1

Additional Pharmacologic Management

H1/H2 Antagonists

  • Diphenhydramine 50 mg IV plus ranitidine 50 mg IV 1

Corticosteroids

  • Methylprednisolone 1-2 mg/kg IV every 6 hours (or equivalent) 1
  • Prevents biphasic reactions but not critical for acute management 1

Cardiovascular Support for Refractory Hypotension

If epinephrine and fluids fail 1:

  • Dopamine: 400 mg in 500 mL dextrose water at 2-20 mcg/kg/min, titrated to response 1
  • Vasopressin: 25 units in 250 mL (0.1 U/mL), dose 0.01-0.04 U/min 1
  • Norepinephrine: may be used if unresponsive to epinephrine 1

Special Circumstances

Bradycardia: atropine 600 mcg IV 1

Beta-blocker therapy: glucagon 1-5 mg IV infusion over 5 minutes for refractory cardiovascular effects 1

Oxygen: administer if needed 1

Post-Reaction Monitoring

  • Monitor vital signs continuously until complete resolution 1
  • 24-hour observation mandatory after severe reactions 1
  • Transport to emergency department preferably by EMS, even if symptoms resolve 1
  • Additional interventions may include supplemental oxygen, IV fluids, and other supportive measures 1

Common Pitfalls to Avoid

Delayed epinephrine administration is the most critical error—this is the leading cause of fatal anaphylaxis 1. Epinephrine must be given immediately upon recognition, not after trying antihistamines or corticosteroids first 1.

Incorrect positioning: allowing patients to stand or walk can precipitate cardiovascular collapse 1.

Premature discharge: patients require extended observation as biphasic reactions can occur hours after initial resolution 1.

Inadequate dosing: using autoinjectors (0.15 mg or 0.3 mg) may be suboptimal for some patients, particularly those at weight extremes 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.